Back to search
FDAFDA · Food and drugs·Recall number D-0070-2024

Oxytocin synthetic, 30 Units added to 0.9% Sodium Chloride 500mL IV Bag (0.06 Units per mL), Rx only, Leiter Compounding Health, 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-157-70

Published November 1, 2023 · Recall initiated: October 4, 2023

Summary

FDA records drug Class III recall D-0070-2024, published November 1, 2023 and initiated October 4, 2023. Recalling firm: Denver Solutions, LLC DBA Leiters Health; Status: Terminated; Reported quantity: 6,276 IV bags; Lot: Lot#: 2330956, Exp. 10/23/2023; 2330964, Exp. 10/24/2023; 2331014, Exp. 11/6/2023; 2331033, Exp. 11/8/2023. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Not Elsewhere Classified

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Denver Solutions, LLC DBA Leiters Health
Distributor
USA Nationwide
Lot
Lot#: 2330956, Exp. 10/23/2023; 2330964, Exp. 10/24/2023; 2331014, Exp. 11/6/2023; 2331033, Exp. 11/8/2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Oxytocin synthetic, 30 Units added to 0.9% Sodium Chloride 500mL IV Bag (0.06 Units per mL), Rx only, Leiter Compounding Health, 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-157-70 recalled?

Yes. FDA published recall D-0070-2024 on November 1, 2023. Reported hazard: Labeling: Not Elsewhere Classified

What should I do if I have this product?

Voluntary: Firm initiated · Letter